DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,244 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $13,120,242 | +10.7% | 52,540 | +2.5% | 0.38% | -6.9% |
Q4 2023 | $11,852,935 | -6.6% | 51,236 | +0.2% | 0.41% | -16.6% |
Q3 2023 | $12,690,439 | +1.5% | 51,150 | -1.8% | 0.49% | +9.2% |
Q2 2023 | $12,499,127 | -4.9% | 52,080 | -0.1% | 0.45% | -11.1% |
Q1 2023 | $13,139,262 | -7.7% | 52,132 | -2.8% | 0.50% | -11.8% |
Q4 2022 | $14,232,086 | +3.3% | 53,621 | +0.5% | 0.57% | -3.4% |
Q3 2022 | $13,778,738 | -2.8% | 53,346 | -4.6% | 0.59% | +4.1% |
Q2 2022 | $14,178,106 | +85635.7% | 55,925 | -0.8% | 0.57% | +3.8% |
Q1 2022 | $16,537 | -99.9% | 56,376 | -1.1% | 0.55% | -5.2% |
Q4 2021 | $18,756,000 | +7.0% | 57,006 | -1.0% | 0.58% | -2.5% |
Q3 2021 | $17,531,000 | +13.0% | 57,586 | -0.4% | 0.59% | +13.0% |
Q2 2021 | $15,521,000 | +18.0% | 57,836 | -1.1% | 0.52% | +10.3% |
Q1 2021 | $13,158,000 | -0.7% | 58,461 | -2.0% | 0.47% | -4.6% |
Q4 2020 | $13,245,000 | +3.1% | 59,625 | -0.1% | 0.50% | -7.1% |
Q3 2020 | $12,852,000 | +21.7% | 59,685 | -0.1% | 0.54% | +9.9% |
Q2 2020 | $10,560,000 | +28.2% | 59,718 | +0.4% | 0.49% | +7.3% |
Q1 2020 | $8,235,000 | -15.5% | 59,498 | -6.3% | 0.45% | +9.9% |
Q4 2019 | $9,750,000 | +4.4% | 63,526 | -1.7% | 0.41% | -3.3% |
Q3 2019 | $9,338,000 | +2.9% | 64,652 | +1.8% | 0.43% | +2.4% |
Q2 2019 | $9,077,000 | +11.7% | 63,515 | +3.2% | 0.42% | +9.4% |
Q1 2019 | $8,127,000 | +25.1% | 61,559 | -2.3% | 0.38% | +10.1% |
Q4 2018 | $6,496,000 | -6.7% | 62,997 | -1.7% | 0.35% | +9.1% |
Q3 2018 | $6,964,000 | +8.0% | 64,097 | -1.9% | 0.32% | -0.6% |
Q2 2018 | $6,449,000 | -1.5% | 65,356 | -2.3% | 0.32% | -2.1% |
Q1 2018 | $6,546,000 | +6.5% | 66,864 | +1.0% | 0.33% | +13.6% |
Q4 2017 | $6,147,000 | +4.9% | 66,234 | -3.0% | 0.29% | 0.0% |
Q3 2017 | $5,858,000 | -1.5% | 68,301 | -3.1% | 0.29% | -3.0% |
Q2 2017 | $5,949,000 | -12.3% | 70,501 | -11.1% | 0.30% | -14.9% |
Q1 2017 | $6,782,000 | +6.9% | 79,301 | -2.7% | 0.35% | +2.7% |
Q4 2016 | $6,343,000 | -10.1% | 81,495 | -9.5% | 0.34% | -9.6% |
Q3 2016 | $7,056,000 | -24.2% | 90,021 | -2.4% | 0.38% | -26.5% |
Q2 2016 | $9,311,000 | +2.0% | 92,196 | -4.2% | 0.51% | +2.4% |
Q1 2016 | $9,127,000 | -1.1% | 96,223 | -3.2% | 0.50% | -1.4% |
Q4 2015 | $9,233,000 | +0.2% | 99,418 | -8.1% | 0.50% | -3.4% |
Q3 2015 | $9,218,000 | -12.8% | 108,182 | -12.5% | 0.52% | -3.9% |
Q2 2015 | $10,577,000 | -4.4% | 123,582 | -5.1% | 0.54% | -0.5% |
Q1 2015 | $11,060,000 | -5.1% | 130,272 | -4.2% | 0.55% | -6.0% |
Q4 2014 | $11,652,000 | +9.4% | 135,955 | -3.0% | 0.58% | +5.8% |
Q3 2014 | $10,646,000 | -6.4% | 140,120 | -3.0% | 0.55% | -4.0% |
Q2 2014 | $11,372,000 | -5.4% | 144,446 | -9.9% | 0.57% | -6.1% |
Q1 2014 | $12,021,000 | -59.2% | 160,288 | -58.0% | 0.61% | -59.0% |
Q4 2013 | $29,481,000 | +12.5% | 381,879 | +1.0% | 1.49% | +0.2% |
Q3 2013 | $26,200,000 | +6.8% | 377,958 | -2.5% | 1.49% | +0.7% |
Q2 2013 | $24,539,000 | – | 387,662 | – | 1.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |